GLPGF - Galapagos Knee Osteoarthritis Data And Other News: The Good Bad And Ugly Of Biopharma
- Galapagos announces topline data from knee osteoarthritis trial.
- Evelo provides updates for EDP1815 in Atopic Dermatitis and Psoriasis trials.
- CTI BioPharma initiates NDA process for Pacritinib.
For further details see:
Galapagos Knee Osteoarthritis Data, And Other News: The Good, Bad And Ugly Of Biopharma